SCHEMBL29944210

SCHEMBL29944210

CCc1cccc(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127952 1.00
Methoxymethane SCHEMBL28044383 0.93 IDO1 (0.53)
Ethylene Glycol SCHEMBL29186510 0.91 TAAR1 (0.48)
Biphenyl SCHEMBL28790402 0.89 TP53 (0.50)
SCHEMBL27815593 0.88 TAAR1 (0.46)
SCHEMBL9289390 0.87 TAAR1 (0.55)
SCHEMBL16301334 0.82 MAOB (0.46)
SCHEMBL20098914 0.82 MAOB (0.71)
Butyric Acid SCHEMBL28256398 0.82 FFAR1 (0.50)
SCHEMBL429765 0.81 TAAR1 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651867-A1 BETA 2-ADRENERGIC RECEPTOR AGONISTS FOR TREATMENT OR PREVENTION OF MUSCLE WASTING Atrogi AB (SE) 2025-11-26 EP disclosed
US-12410174-B1 Small molecular inhibitors of sting signaling compositions and methods of use TYERELL IMMUNOTHERAPEUTICS INC (US) 2025-09-09 US disclosed
WO-2024153813-A1 BETA 2-ADRENERGIC RECEPTOR AGONISTS FOR TREATMENT OR PREVENTION OF MUSCLE WASTING ATROGI AB (SE) 2024-07-25 WO disclosed
CN-118184558-A Thiophenylamide compound, and preparation method and application thereof 五邑大学 2024-06-14 CN disclosed
CN-117810539-B Electrolyte additive, nonaqueous electrolyte and lithium ion battery 如鲲(江苏)新材料科技有限公司 2024-05-24 CN disclosed
CN-117810539-A Electrolyte additive, nonaqueous electrolyte and lithium ion battery 如鲲(江苏)新材料科技有限公司 2024-04-02 CN disclosed
US-11897888-B1 Small molecular inhibitors of sting signaling compositions and methods of use STINGINN LLC (US) 2024-02-13 US disclosed
WO-2023040830-A1 AHR INHIBITOR, USE THEREOF, AND PREPARATION METHOD THEREFOR 北京华森英诺生物科技有限公司 2023-03-23 WO disclosed
CN-110128393-B Preparation method of substituted isocoumarin derivative 华侨大学 2022-09-30 CN disclosed